144 related articles for article (PubMed ID: 8528727)
1. Characterization of an antigen shared by human thymic epithelium and human T cell leukemia virus p19 Gag protein.
Palker TJ; Singer KH; Vahlne A
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):10-9. PubMed ID: 8528727
[TBL] [Abstract][Full Text] [Related]
2. Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.
Sato A; Isaka Y; Morita F; Ishii A; Goto Y; Imai J; Igarashi H; Yoshie O; Hinuma Y
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2969-73. PubMed ID: 1279104
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny.
Haynes BF; Robert-Guroff M; Metzgar RS; Franchini G; Kalyanaraman VS; Palker TJ; Gallo RC
J Exp Med; 1983 Mar; 157(3):907-20. PubMed ID: 6833950
[TBL] [Abstract][Full Text] [Related]
4. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
[TBL] [Abstract][Full Text] [Related]
6. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
Lal RB; Brodine SK; Coligan JE; Roberts CR
J Med Virol; 1991 Dec; 35(4):232-6. PubMed ID: 1687064
[TBL] [Abstract][Full Text] [Related]
7. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural localization of HTLV-I gag proteins p19 and p24 by single and double immunogold labeling.
Stransky G; Gay S
J Histochem Cytochem; 1991 Feb; 39(2):185-91. PubMed ID: 1987262
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I.
Edouard E; Legrand E; Astier-Gin T; Dalibart R; Geoffre S; Dalbon P; Guillemain B; Londos-Gagliardi D
Leukemia; 1994 Apr; 8 Suppl 1():S60-4. PubMed ID: 7512182
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
[TBL] [Abstract][Full Text] [Related]
11. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
12. C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
Palker TJ; Scearce RM; Copeland TD; Oroszlan S; Haynes BF
J Immunol; 1986 Apr; 136(7):2393-7. PubMed ID: 2419433
[TBL] [Abstract][Full Text] [Related]
13. Study of the peptide length and amino acid specific substitution in the antigenic activity of the chimeric synthetic peptides, containing the p19 core and gp46 envelope proteins of the HTLV-I virus.
Marin MH; Rodríguez-Tanty C; Higginson-Clarke D; Bocalandro YM; Peña LP
Biochem Biophys Res Commun; 2005 Oct; 336(3):983-6. PubMed ID: 16157308
[TBL] [Abstract][Full Text] [Related]
14. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
Lal RB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S170-8. PubMed ID: 8797720
[TBL] [Abstract][Full Text] [Related]
15. Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.
Tanaka Y; Yoshida A; Tozawa H; Shida H; Nyunoya H; Shimotohno K
Int J Cancer; 1991 Jun; 48(4):623-30. PubMed ID: 1710610
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
[TBL] [Abstract][Full Text] [Related]
17. A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
Arp J; LeVatte M; Rowe J; Perkins S; King E; Leystra-Lantz C; Foung SK; Dekaban GA
J Virol; 1996 Nov; 70(11):7349-59. PubMed ID: 8892853
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell-leukemia virus-type-II (HTLV-II).
Tanaka Y; Tanaka R; Hoshino H
Int J Cancer; 1994 Dec; 59(5):655-60. PubMed ID: 7525496
[TBL] [Abstract][Full Text] [Related]
19. Identification of a type-specific protein that differentiates serologically between human T cell lymphotropic virus types I and II.
Carrera-Zandomeni M; Zandomeni R; Esteban EN; Ferrer JF
J Infect Dis; 1993 May; 167(5):1021-6. PubMed ID: 8486936
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of a monoclonal antibody directed against HTLV-1 p19: use in a specific capture enzyme immunoassay.
Ebersold A; Noraz N; Grange J; Gasmi M; Grange MP; Souche S; Mamoun R; Desgranges C
Hybridoma; 1993 Apr; 12(2):185-95. PubMed ID: 7686136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
